Pharma, biotech, and medical device companies are increasingly turning to contract research organizations to outsource a wide range of activities through functional service provider (FSP) arrangements. FSPs increase agility and drive down costs while offering cafeteria-style flexibility — giving clients wide latitude in choosing which services to farm out and which to keep in house.
Functional Service Provider (FSP)
DURHAM, N.C., March 30, 2018 — Predicting the cost of clinical trials is a complex task, and more CROs are providing grant forecasting as a service to produce more accurate projections and give customers greater visibility. A grant forecasting expert from Premier Research will discuss new approaches to predicting trial costs in April at the...
When the going gets tough, the tough get … creative. The search for the best resourcing solution sometimes defies a single answer. That’s when Premier Research combines outsourcing, insourcing, and geographic flexibility to devise a hybrid solution.
A U.S. pharmaceutical company needed an immediate outsourcing solution to replace an underperforming vendor. Not only was time critical, cost was, too. These new data specialists would be located offshore to reduce the sponsor’s overhead. Oh, and did we mention it had to be done fast?
Functional outsourcing can produce significant savings and greatly increase flexibility in assigning resources. But any big change in staffing requires care to avoid personnel disruptions, keep projects on track, and comply with laws governing use of contract employees.
Premier Research is at the forefront of offering secure file-transfer services for pharma companies. Unlike other providers of secure file hosting, we understand the needs that are specific to the industry — such as giving all trial participants upload and download access while building in firewalls between lab vendors.
Applied Clinical Trials – The Growing Role of Performance Incentives Between Sponsors, CROsby Sean Russell, Chief Commercial Officer
In clinical drug research, time is of the essence. Not only are researchers, in many cases, trying to beat their competitors to market, their ability to conduct a timely clinical trial can be the difference between life and death for the target audience. The question is, then, how do you as a sponsor get your contract research organizations...
SCRIP – The CRO View: Sharing Opportunity Vs Risk In Drug Developmentby Sean Russell, Chief Commercial Officer
Drug Development & Discovery – The Opportunity in Sharing Risk: A Productive Trend in Clinical Trials
Drug Development & Discovery – The Opportunity in Sharing Risk: A Productive Trend in Clinical Trialsby Sean Russell, Chief Commercial Officer